You just read:

AcelRx Pharmaceuticals announces publication analyzing pooled data on sufentanil sublingual tablets for short-term treatment of moderate-to-severe acute pain

News provided by

AcelRx Pharmaceuticals, Inc.

Jan 07, 2019, 08:30 ET